The American Association of Cancer Research recently released its 2017 Cancer Progress Report. Here are the highlights of nine newly approved cancer drugs—two checkpoint inhibitors and molecularly targeted therapeutics—and an historic first for a previously…

https://doi.org/10.18632/oncotarget.21348 Jean-François Laes, Sebastien Sauvage, Gregori Ghitti

Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.